X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with VENKYS (I) LIMITED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VENKYS (I) LIMITED - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VENKYS (I) LIMITED GSK CONSUMER/
VENKYS (I) LIMITED
 
P/E (TTM) x 31.3 14.6 214.8% View Chart
P/BV x 8.8 3.5 250.8% View Chart
Dividend Yield % 1.0 0.4 230.7%  

Financials

 GSK CONSUMER   VENKYS (I) LIMITED
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
VENKYS (I) LIMITED
Mar-18
GSK CONSUMER/
VENKYS (I) LIMITED
5-Yr Chart
Click to enlarge
High Rs6,7934,560 149.0%   
Low Rs4,9191,000 491.9%   
Sales per share (Unadj.) Rs1,026.31,908.3 53.8%  
Earnings per share (Unadj.) Rs166.5141.7 117.4%  
Cash flow per share (Unadj.) Rs181.8161.7 112.4%  
Dividends per share (Unadj.) Rs75.008.00 937.5%  
Dividend yield (eoy) %1.30.3 445.1%  
Book value per share (Unadj.) Rs828.6511.8 161.9%  
Shares outstanding (eoy) m42.0614.09 298.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.71.5 391.7%   
Avg P/E ratio x35.219.6 179.4%  
P/CF ratio (eoy) x32.217.2 187.4%  
Price / Book Value ratio x7.15.4 130.1%  
Dividend payout %45.15.6 798.3%   
Avg Mkt Cap Rs m246,28439,170 628.8%   
No. of employees `0004.05.4 74.2%   
Total wages/salary Rs m5,2771,707 309.1%   
Avg. sales/employee Rs Th10,837.35,010.8 216.3%   
Avg. wages/employee Rs Th1,325.0318.2 416.4%   
Avg. net profit/employee Rs Th1,757.7372.2 472.3%   
INCOME DATA
Net Sales Rs m43,16526,888 160.5%  
Other income Rs m2,574262 981.7%   
Total revenues Rs m45,73927,150 168.5%   
Gross profit Rs m8,8343,887 227.2%  
Depreciation Rs m644281 228.8%   
Interest Rs m20499 4.1%   
Profit before tax Rs m10,7443,370 318.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7431,373 272.7%   
Profit after tax Rs m7,0011,997 350.6%  
Gross profit margin %20.514.5 141.5%  
Effective tax rate %34.840.7 85.5%   
Net profit margin %16.27.4 218.4%  
BALANCE SHEET DATA
Current assets Rs m45,6207,938 574.7%   
Current liabilities Rs m17,4265,900 295.4%   
Net working cap to sales %65.37.6 861.5%  
Current ratio x2.61.3 194.6%  
Inventory Days Days3540 85.5%  
Debtors Days Days2440 58.8%  
Net fixed assets Rs m5,1384,764 107.9%   
Share capital Rs m421141 298.5%   
"Free" reserves Rs m34,4317,071 486.9%   
Net worth Rs m34,8517,212 483.3%   
Long term debt Rs m0739 0.0%   
Total assets Rs m54,12714,312 378.2%  
Interest coverage x530.27.8 6,835.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.81.9 42.4%   
Return on assets %13.017.4 74.4%  
Return on equity %20.127.7 72.5%  
Return on capital %30.948.7 63.5%  
Exports to sales %00.2 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA62 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,01462 4,845.6%   
Fx outflow Rs m18664 290.4%   
Net fx Rs m2,828-2 -166,376.5%   
CASH FLOW
From Operations Rs m7,2302,559 282.5%  
From Investments Rs m-4,465-293 1,524.2%  
From Financial Activity Rs m-3,634-2,448 148.4%  
Net Cashflow Rs m-868-182 477.2%  

Share Holding

Indian Promoters % 0.0 56.1 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 8.8 9.1%  
FIIs % 12.0 3.2 381.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 31.9 46.4%  
Shareholders   26,457 20,089 131.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   RADICO KHAITAN  TATA COFFEE  GOODRICKE  ADVANTA LTD.  REI AGRO LTD.  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

VENKYS (I) LIMITED Surges by 10%; BSE 500 Index Up 1.8% (Market Updates)

May 24, 2019 | Updated on May 24, 2019

VENKYS (I) LIMITED share price has surged by 10% and its current market price is Rs 1,809. The BSE 500 is up by 1.8%. The top gainers in the BSE 500 Index are VENKYS (I) LIMITED (up 10.4%) and HEG (up 11.2%). The top losers are TCS (down 0.1%) and TORRENT POWER LTD (down 0.1%).

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VENKYS (I) LIMITED Announces Quarterly Results (4QFY19); Net Profit Down 41.5% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, VENKYS (I) LIMITED has posted a net profit of Rs 299 m (down 41.5% YoY). Sales on the other hand came in at Rs 8 bn (up 11.8% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Feb 18, 2019 | Updated on Feb 18, 2019

For the quarter ended December 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 35.1% YoY). Sales on the other hand came in at Rs 11 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VENKYS (I) LIMITED Announces Quarterly Results (3QFY19); Net Profit Down 2.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, VENKYS (I) LIMITED has posted a net profit of Rs 677 m (down 2.5% YoY). Sales on the other hand came in at Rs 8 bn (up 16.7% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


May 24, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS